Blog

Stem Cell Therapy for Hair Loss in 2026: What the Science Actually Shows

From MSC secretome to exosome injections and next-gen PRP alternatives, here is what 2026 research says about regenerative hair loss treatments — and who they work best for.

Oct 24, 2026

MSC Therapy for Alzheimer’s Disease: Clinical Trial Data on Laromestrocel and Biomarker Outcomes

Recent Phase 2a clinical trials demonstrate that mesenchymal stem cell therapy can slow brain atrophy by up to 62% and reduce neuroinflammation in mild Alzheimer's patients. Review of laromestrocel trial data, biomarker …

Oct 22, 2026

MSC Therapy for Systemic Sclerosis: iPSC-Derived Stem Cells, Clinical Trials, and the Vasculopathy-Fibrosis Mechanism

A comprehensive 2026 review of mesenchymal stem cell therapy for systemic sclerosis (scleroderma), covering iPSC-derived MSCs, refrigerated cell delivery, blood vessel organoid models, and the MANUS clinical trial for di…

Oct 21, 2026

Can Stem Cells Restore Your Fertility? What Research Shows About Ovarian Regeneration

Premature ovarian insufficiency doesn't have to mean permanent infertility. Learn how 2026 stem cell research is restoring ovarian function, hormone levels, and natural fertility in women with POI—with real clinical evid…

Oct 20, 2026

MSC Therapy for Atopic Dermatitis: Meta-Analysis of RCTs and Phase 2 Data Reveal

A 2026 meta-analysis pools 236 patients across 5 trials, and a 114-patient Phase 2 RCT shows MSC therapy achieves EASI-75 in 24% of severe AD patients. Exosome hydrogel delivery and batch consistency data now address the…

Oct 18, 2026

MSC Therapy for Parkinson’s Disease: What Randomized Trials and Comprehensive Reviews Reveal

Multiple 2026 clinical trials and reviews show mesenchymal stem cell therapy is safe and feasible for Parkinson's disease — but what do the actual data say about efficacy, dosing, and what comes next?

Oct 16, 2026

MSC Therapy for Pediatric Acute GvHD: From FDA Approval to Next-Generation Approaches

The first FDA-approved MSC therapy (Ryoncil) ended a 20-year drought for cell-based products in the US. New real-world data from 139 children and next-generation platforms are reshaping how clinicians treat steroid-refra…

Oct 15, 2026

Can Stem Cell Therapy Help Children with Autism? What 2026 Research Shows

A double-blind RCT shows cord blood stem cells improved social cognition in children with autism. Here's what parents need to know about the latest research, safety data, and treatment process.

Oct 14, 2026

MSC Therapy for Chronic Kidney Disease: What the 2025 Evidence Shows

A 2025 meta-analysis of 52 studies, real-world Taiwan data, and Mayo Clinic intraarterial delivery results — what nephrologists need to know about MSCs and CKD.

Oct 14, 2026

MSC Therapy for Pulmonary Fibrosis: 2026 Preclinical and Clinical Evidence Review

A medical review of MSC-based and MSC-derived EV therapies for idiopathic pulmonary fibrosis, covering meta-analysis data, immune-cloaked cell engineering, nebulized exosome delivery, gut-lung axis mechanisms, and active…

Sep 23, 2026

MSC Therapy for Ischemic Stroke: What a 2026 Umbrella Review and Network Meta-Analysis of 1,006 Patients Reveal

The 2026 evidence base for mesenchymal stem cell therapy in ischemic stroke includes a 26-study umbrella review and an 18-RCT network meta-analysis of 1,006 patients. MSCs were the only cell type to significantly reduce …

Sep 7, 2026

Pourquoi vos cellules souches ralentissent après 40 ans (et ce que la science fait pour y remédier)

Research shows MSC activity drops 40% by age 50. Learn what changes inside aging cells and three emerging therapies showing real results in 2026 clinical trials.

Sep 4, 2026

Page 1 of 6 — 72 posts